Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-17 · accession 0001689375-25-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-19 | 2025-03-17 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $10.67 | -1,784 | 109.5K | -2% | -$19.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | S | D | 1,784 | $10.67 | 109,536 | D | — | — |